Medrol

Methylprednisolone, the active ingredient in Medrol, is a glucocorticoid presented as an oral tablet for oral use. It treats inflammatory and immune‑mediated conditions in adults and children as directed by a prescriber.

GNH USA supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medrol (methylprednisolone) is used to modulate inflammation and immune responses in several disease groups.

Allergic reactions: reduces symptoms such as swelling, itching and airway constriction. Asthma: improves airway inflammation and helps prevent exacerbations. Rheumatoid arthritis: decreases joint inflammation and pain, slowing disease progression. Dermatologic inflammatory conditions: alleviates skin inflammation in conditions like eczema and psoriasis. Autoimmune diseases: suppresses abnormal immune activity in disorders such as systemic lupus erythematosus.

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased appetite and weight gain. - Insomnia or mood changes. - Elevated blood glucose levels. - Gastrointestinal discomfort or dyspepsia. - Fluid retention and mild hypertension.

Serious or Rare Side Effects: - Adrenal suppression leading to crisis. - Severe infections, including opportunistic pathogens. - Osteoporosis with long‑term use. - Cataracts or glaucoma. - Psychosis or severe mood disorders. - Anaphylactic or severe allergic reactions.

When prescribing methylprednisolone, clinicians should consider several safety measures to minimize risk.

Assess infection risk: evaluate for active or latent infections before initiating therapy. Monitor blood glucose: check glucose levels regularly, especially in diabetic patients. Taper when discontinuing: gradually reduce dose to avoid adrenal insufficiency. Avoid in systemic fungal infection: contraindicated in patients with uncontrolled fungal disease. Use with caution in pregnancy: limited data; weigh benefits against potential risks. Store at room temperature: keep in original packaging, protect from moisture and heat.

Methylprednisolone can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase steroid levels. - Live vaccines: risk of inadequate immune response or infection. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin) may reduce effectiveness. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal bleeding.